Immunization with Plasmodium sporozoites that have been attenuated by ␥-irradiation or specific genetic modification can induce protective immunity against subsequent malaria infection. The mechanism of protection is only known for radiation-attenuated sporozoites, involving cell-mediated and humoral immune responses invoked by infected hepatocytes cells that contain longlived, partially developed parasites. Here we analyzed sporozoites of Plasmodium berghei that are deficient in P36p (p36p ؊ ), a member of the P48͞45 family of surface proteins. P36p plays no role in the ability of sporozoites to infect and traverse hepatocytes, but p36p ؊ sporozoites abort during development within the hepatocyte. Immunization with p36p ؊ sporozoites results in a protective immunity against subsequent challenge with infectious wild-type sporozoites, another example of a specifically genetically attenuated sporozoite (GAS) conferring protective immunity. Comparison of biological characteristics of p36p ؊ sporozoites with radiation-attenuated sporozoites demonstrates that liver cells infected with p36p ؊ sporozoites disappear rapidly as a result of apoptosis of host cells that may potentiate the immune response. Such knowledge of the biological characteristics of GAS and their evoked immune responses are essential for further investigation of the utility of an optimized GAS-based malaria vaccine.
U
pon introduction into the bloodstream by the female Anopheline mosquito during blood feeding, the infectious sporozoite of Plasmodium invades and multiplies within the hepatocyte. Recognition and invasion of a hepatocyte is a complex process involving traversal through macrophage-like Kupffer cells (1) and several hepatocytes (2) before forming a parasitophorous vacuole (PV) in the final hepatocyte. Currently, only a few proteins of sporozoites have been described that play an essential role in establishing infection of the liver but are thought to be conserved in all species of Plasmodium. These include circumsporozoite protein (CS), thrombospondin-related anonymous protein (TRAP), microneme proteins essential for cell traversal (SPECT1, SPECT2 or PPLP1, and CelTOS) and PbIMC1a, which variously are involved in motility of sporozoites, recognition of surface receptors on host cells, and traversal and invasion of host cells (3) (4) (5) (6) (7) (8) (9) (10) . Within the PV, the sporozoite transforms and grows (trophozoite stage) and multiplies (schizont stage) for a period of a few days, resulting in the generation and release of thousands of merozoites that invade red blood cells.
The current rationale for the characterization of Plasmodium molecules involved in liver infection lies in the development of a (subunit) vaccine that protects against liver and subsequent blood stage infection (11) . Immunization studies using complete radiation-attenuated sporozoites (RAS) showed full protection against subsequent challenge with infectious sporozoites in both animal models of malaria and in human volunteers (12) . The protective immunity that is observed after immunization with RAS requires that the sporozoites infect hepatocytes and transform into the trophozoite stage (13) . Such immunity is mediated by complex mechanisms involving antibody responses that inhibit sporozoite motility and host cell invasion and T cell responses directed against intrahepatocytic stages. CD4
ϩ T helper cells and cytotoxic CD8 ϩ T lymphocytes recognizing MHC presented parasite-derived peptides, as well as cytokines (IL-2, IFN-␥, and IL-12; TNF-␣, IL-1, and IL-6) and nitric oxide, have been shown to be critical effectors in protection against preerythrocytic malaria (13) (14) (15) .
However, vaccination studies with subunit vaccines that contain only (parts of) single proteins of sporozoites have failed so far to provide any significant, long-lasting protective immunity (11, 12) . The lack of significant progress with subunit vaccines stimulated recent attempts to produce a vaccine based on the nonreplicating, metabolically active RAS (12) . However, such vaccines suffer from significant drawbacks, not least the question of safety and reproducibility because the amount of radiation that generates the attenuated state is strictly defined. Parasites that are underirradiated remain infectious, and those that are overirradiated do not induce protective immunity. Recently, it has been shown that genetically attenuated sporozoites (GAS) that lack sporozoitespecific conserved genes (uis3 and uis4) that are apparently important for sporozoite development in the hepatocyte can induce significant or complete protective immunity in the P. berghei rodent model of malaria when different immunization protocols are used (16, 17) . The use of GAS for vaccination might remove the uncertainty associated with RAS once a more thorough understanding of the mechanisms of immunity invoked by GAS and their developmental defect(s) are available.
In this study, we generated a GAS in P. berghei that lacks the sporozoite-specific protein P36p (refs. 18 and 19, and E. Lasonder, personal communication), which is a member of a small family of 10 Plasmodium surface proteins, the P48͞45 family, that include other promising vaccine candidate antigens (20) (21) (22) . Development of p36p Ϫ parasites aborts within the hepatocyte and immunization with p36p Ϫ sporozoites induces protective immune responses against subsequent challenges with wild-type sporozoites. P36p-deficient parasitized cell numbers are progressively reduced after 24 h in culture and in vivo and apparently fail to prevent host cell apoptosis, consequently leading to parasite clearance. Generation and analysis of biological and immunogenic characteristics of multiple GAS models are essential for further development of GAS as a potential malaria vaccine.
Materials and Methods
Generation of the p36p ؊ Parasite Lines. To disrupt the p36p locus a p36p replacement vector was constructed in vector b3D.D T .ٙH. ٙD b containing the pyrimethamine-resistant Toxoplasma gondii (tg) dhfr͞ts gene. To introduce gfp into the genome of p36p Ϫ parasites, a vector was constructed with the human (h) dhfr selectable marker and gfp under control of the constitutive pbef-1aa promoter (23) (24) (25) and a fragment of 2 kb of the D-type small subunit (dssu) rRNA gene of P. berghei (22) . The linearized vector can integrate in C-type small subunit (cssu) and͞or dssu. Integration into cssu does not affect the phenotype of the parasites (26). For further details, see Supporting Text, which is published as supporting information on the PNAS web site.
P. berghei wild-type (WT) parasites (clone 15cy1; ANKA strain) were used to generate p36p Ϫ parasites. Transfection, selection, and cloning of p36p Ϫ parasites was performed as described (27) . Two independent transfection experiments were performed, and two clones (KO1 and KO2) were selected for further analysis. p36p Ϫ parasites (KO1) were transfected with the gfp vector to create p36p Ϫ mutants expressing gfp constitutively throughout the life cycle. Selection of transformed parasites was performed by treating infected animals with WR99210 (16 mg͞kg bodyweight) as has been described (25) . One parasite clone (KOGFP) in which the gfp was integrated into the cssu was selected for further analysis. Correct integration of constructs into the genome of transformed parasites was analyzed by RT-PCR and Southern analysis of restricted DNA or separated chromosomes by field inversion gel electrophoresis (27) . PCR on DNA of WT and p36p Ϫ parasites was performed by using primers specific for the WT (L1362 5Ј-CCGCTCGAGAC-CTTAGGACACTTTGAAATTTG-3Ј and L1363 5Ј-CCGCTC-GAGCTACTCATAATAAGAAGAAGAGGTAC-3Ј; amplifying a fragment of 1.2 kb) and disrupted (L1389 5Ј-ATTTTG-CAACAATTTTATTCTTGG-3Ј and L313 5Ј-ACGCAT-TATATGAGTTCATTTTAC-3Ј; amplifying a fragment of 1.0 kb) locus. PCR on DNA of WT and p36p Ϫ :gfp parasites was performed by using primers specific for WT (L270 5Ј-GTGTAGTAACAT-CAGTTATTGTGTG-3Ј and L271 5Ј-CTTAGTGTTTTGTAT-TAATGACGATTTG-3Ј, amplifying a fragment of 3 kb) and disrupted cssu (L270 and L635 5Ј-TTTCCCAGTCAC-GACGTTG-3Ј, amplifying a fragment of 3 kb). Primers 1389 and 313 amplified the expected fragment of 1.0 kb of the disrupted p36p locus in KOGFP parasites. RT-PCR was performed on RNA isolated from WT and p36p Ϫ sporozoites as described by Invitrogen. To amplify cDNA derived from the p36p Ϫ or circumsporozoite (CS) gene, primers L1425 (5Ј-GAAATGAATATGTCGGTAC-TATG-3Ј) and L1363 (5Ј-CCGCTCGAGCTACTCATAATAA-GAAGAAGAGGTAC-3Ј), amplifying a fragment of 0.5 kb, and L1502 (5Ј-AGTCAACAGATTATTGCCGATG-3Ј) and L1503 (5Ј-TACAAATCCTAATGAATTGCTTAC-3Ј), amplifying a 0.8-kb fragment, were used, respectively.
Phenotype Analysis of the p36p ؊ Parasite During Blood Stage and Mosquito Stage Development. The phenotype of blood stage development was analyzed in asynchronous infections in Swiss mice and during standardized synchronized development in vivo and in vitro as described (28) . Gamete formation, fertilization and ookinete production were studied in vitro as described (20) . Oocyst formation and sporozoite development were investigated by using Anopheles stephensi and standard methodologies (29) . The number of sporozoites per salivary gland was determined by mixing the salivary glands of 10 infected mosquitoes in 300 l of PBS and counting the numbers of sporozoites in duplicate in a cell counter. The capacity of p36p Ϫ sporozoites to establish blood stage infections was established by infection of mice (female BALB͞c and C57BL6, 15-20 g) through bites of infected mosquitoes or i.v. injection of 5 ϫ 10 4 purified sporozoites, dissected from infected mosquito salivary glands (30) , per mouse. Twenty to 40 infected mosquitoes were allowed to feed on each mouse 20 days after the infectious blood meal. Blood stage infections were monitored in Giemsa-stained bloodsmears or by FACS analysis of tail blood when p36p Ϫ :gfp parasites were used (23) on days 4-14 after infection. Infection with WT sporozoites results in a 1-10% para- sitemia at day 4-6 after mosquito feeding and a 0.5-5% parasitemia on day 4 or 5 after i.v. injection.
Gliding motility of sporozoites was analyzed by counting the average number of circles performed by single sporozoites (31) . Sporozoites (4 ϫ 10 4 ) were spun for 10 min at 1,800 ϫ g onto glass coverslips previously coated with 0.02% gelatin in water, followed by incubation for 2 h at 37°C and staining with anti-CS 3D11 antibody (Ab) for sporozoite and trail visualization. Quantification was performed by counting the average number of circles performed by 100 sporozoites in three independent coverslips. Hepatocyte invasion and traversal were studied in vitro by adding purified sporozoites to confluent monolayers of HepG2 cells in supplemented MEM medium as described (32) . Cell traversal was quantified by counting parasite-wounded hepatocytes using a cellimpermeant fluorescent tracer macromolecule, rhodamine-dextran (1 mg͞ml) (2). Hepatocyte invasion was determined by counting the percentage of sporozoites inside dextran-negative cells as described (33) . Sporozoite development within HepG2 cells in vitro was determined by staining cells using different Abs: anti-PbEXP-1, detecting a PVM-resident protein (V.H., unpublished results); and anti-HSP90 (V.H., unpublished results) or anti-HSP70 (2), detecting the parasite cytoplasmic heat shock protein 90 or 70, respectively. Cells were stained with DAPI to visualize the nuclei. Trophozoite development was quantified by counting the numbers of trophozoites 24 h after invasion of sporozoites in a whole coverslip.
In Vitro Analysis of Apoptosis in RAS and p36p ؊ Parasite-Invaded Hepatocytes. Two distinct fluorescent methods for apoptosis detection were used: (i) active caspase-3 detection, and (ii) nuclear morphology by DAPI staining as described (34) . A total of 3 ϫ 10 4 sporozoites (WT, p36p Ϫ , or RAS; gamma source, 16 Krad, ref. 35 ) were added to monolayers of 2 ϫ 10 5 HepG2 cells (DMEM͞10% FCS͞1% penicillin͞streptomycin͞1 mM glutamine) for 6 h before staining with anti-HSP70 Ab (2) for parasite detection. Apoptotic cells were visualized 6 h after infection by using an active caspase-3 detection kit (Promega) and DAPI staining. Infection and apoptosis rates were quantified by counting the number of parasiteinfected cells per coverslip and apoptotic parasite-infected cells per coverslip respectively, in triplicate.
In Vivo Analysis of Apoptosis in p36p ؊ Parasite-Invaded Hepatocytes.
Two C57BL͞6 mice per group were infected with 5 ϫ 10 5 p36p Ϫ or WT sporozoites by i.v. injection. Livers were removed 6 h after infection and snap-frozen, and 20 histological sections from each mouse were stained for both parasite detection (anti-HSP70; ref.
2) and nuclear morphology by DAPI staining. All sections were examined for the presence of infected cells with signs of apoptosis.
Analysis of the Immunization Potential of p36p ؊ Sporozoites. Groups of BALB͞c and C57BL6 mice were immunized by i.v. injection of p36p Ϫ sporozoites or RAS (35) or PBS and monitored for blood stage parasitaemia in Giemsa-stained bloodsmears. Mice were challenged with different doses of WT sporozoites on different time points. Animals were either monitored for blood stage parasitemia in bloodsmears every other day starting from day 3 to 3 weeks after challenge or killed 40 h after challenge for liver extraction and quantification of infection by real-time PCR quantification of A-type 18S ribosomal RNA copies (36) . For each set of experiments, groups of naïve mice were included to verify infectivity of the sporozoite challenge dose.
Results
Generation and Characterization of p36p ؊ and p36p ؊ :gfp P. berghei Parasites. To investigate the function of P36p, we created two independent, cloned lines of P. berghei parasites that are deficient in P36p (p36p Ϫ ) by using targeted disruption of the P36p gene through double crossover homologous recombination (27) (Fig. 1) . In addition, to better visualize and count the p36p Ϫ parasites, we introduced gfp under control of a constitutive promoter in the genome of one of the p36p Ϫ lines (p36p Ϫ :gfp; Fig. 1 ). The inability of the p36p Ϫ parasites to produce transcripts of p36p and thus express P36p in sporozoites was shown by RT-PCR (Fig. 1) . All three p36p Ϫ lines show no phenotype that is different from WT parasites during blood stage development (results not shown) and development in the mosquito. The characteristics of fertilization and zygote development as well as oocyst and sporozoite production in the mosquito were not affected in the independent p36p Ϫ lines (Table 1) .
P36p Is Essential for Sporozoite Development within the Hepatocyte.
The infectivity of p36p Ϫ sporozoites to the host (BALB͞c and C57BL6 mice) was strongly affected, as was shown by the complete absence of a blood stage infection after infection through the bite of mosquitoes or after i.v. inoculation of purified salivary gland sporozoites (Table 1) . However, occasionally, some mice from both host strains (10% C57BL6, i.e., 5 of 48 mice; 4% BALB͞c, i.e., 1 of (19) . † Mean number (and range) of oocysts in mosquitoes at day 10 after feeding on infected mice and mean number of sporozoites per salivary gland in glands dissected from mosquitoes at day 20 after the infectious blood meal. ‡ Number of mice that became positive after feeding of 20 -40 infected mosquitoes at day 20 after the infectious blood meal. The total number of mice that were exposed to mosquito infection are shown in parentheses. In experiments using WT parasites, all mice became positive with a parasitemia of 1-10% on day 4 or 6 after infection. § Number of mice that became positive after i.v. injection of 5 ϫ 10 4 sporozoites. The total number of mice that were injected with sporozoites are shown in parentheses. In experiments using WT sporozoites, all mice became positive with a parasitemia of 0.5-5% on day 4 or 5 after infection. ¶ The gliding motility of sporozoites is defined as the average number of circles performed by a single sporozoite. The capacity of sporozoites to traverse hepatocytes is defined as the percentage of dextran positive hepatocytes in vitro 2 h after adding sporozoites to hepatocytes. **Hepatocyte invasion was determined by counting the number dextran-negative hepatocytes containing sporozoites, 2 h after adding sporozoites to hepatocytes in vitro. † † Parasite development in hepatocytes was determined by counting trophozoites present at 24 h after invasion of sporozoites into hepatocytes in vitro. 26 mice) did develop a 7-day delayed blood stage infection upon i.v. injection of p36p Ϫ sporozoites in a parasite dose-independent fashion (data not shown). Interestingly, blood stage infections were never observed when p36p Ϫ sporozoites were transmitted naturally through mosquito bites. The resulting blood stage parasites still contained the knockout genotype, as analyzed by PCR (data not shown).
Gliding motility is a feature of Plasmodium sporozoites and associated with invasion of both salivary glands and hepatocytes (4) . p36p Ϫ sporozoites are unaffected in their ability to glide (Table 1 ) and, therefore, the loss of infectivity of these sporozoites is not due to disrupted motility.
We analyzed the ability of p36p Ϫ sporozoites to traverse and infect human hepatocyte cells (HepG2) in culture. HepG2 cells support full exoerythrocytic development of P. berghei sporozoites into mature schizonts containing erythrocyte-infectious merozoites (37) . p36p Ϫ sporozoites were able to traverse and infect hepatocytes as well as WT sporozoites (Table 1) .
Sporozoite invasion of hepatocytes requires sporozoite apical secretion, permitting the subsequent formation of a PV within which the developing parasite resides (38) . Induction of apical secretion by incubation of sporozoites with HepG2 cell extracts showed that both WT and p36p Ϫ sporozoites present a similar level of activation of the apical complex (data not shown). Immunofluorescent antibody test analysis revealed that WT sporozoites generate a clearly visible PV membrane (PVM) formation containing PbExp1, a PVM-resident protein, in infected HepG2 cells that is completely absent in HepG2 cells at 15 and 24 h after infection by p36p Ϫ sporozoites (Fig. 2) . In sharp contrast to WT sporozoites, which gave rise to mature schizonts after 60-72 h of in vitro culture in HepG2 cells, p36p Ϫ sporozoites develop poorly (Fig. 2) , and most parasitised hepatocytes could no longer be detected after 24 h (Table 1) . Equal numbers of p36p Ϫ , RAS, and WT sporozoites were observed in dextran-impermeant hepatocytes; therefore, p36p Ϫ sporozoites might initiate but not maintain a PVM in HepG2 cells.
The aborted development of p36p Ϫ sporozoites shows several similar characteristics to the aborted development of RAS, yet trophozoite development of p36p Ϫ parasites is aborted at an earlier stage compared to RAS (Fig. 2). p36p ؊ Sporozoite-Infected Hepatocytes Enter Apoptosis More Frequently than RAS or WT Parasite-Infected Hepatocytes. Host hepatocyte apoptosis is normally inhibited by WT parasites upon invasion and establishment of the PV (34). Therefore, it was possible that the observed rapid disappearance of p36p Ϫ sporozoite-infected HepG2 cells in culture was due to the inability of the parasite to prevent the hepatocyte from undergoing apoptosis. Consequently, the level of apoptosis in p36p Ϫ sporozoiteinvaded cells was examined (Fig. 3A) . In three independent experiments, HepG2 cells were incubated with WT, RAS, or p36p Ϫ sporozoites, and apoptosis was determined 6 h after infection by detection of active caspase-3 in the infected host cell cytoplasm and by analysis of the nuclear morphology of the infected cells after DAPI staining by observing chromatin condensation and͞or nuclear fragmentation (Fig. 3B) . Interestingly, we also detected apoptosis of p36p Ϫ parasitized hepatocytes in vivo 6 h after infection (Fig. 3C) . The level of apoptosis in p36p Ϫ parasitized cells was significantly higher (P Ͻ 0.05) compared to that in RAS-infected cells, which was higher than the level observed in WT-infected cells (Fig. 3A) . The different levels of apoptosis are consistent with the observed longer survival time of RAS in culture (39) .
Immunization with p36p ؊ Sporozoites Protects BALB͞c and C57BL6
Mice Against Subsequent Infection. Because RAS has been successfully used in immunization studies for generation of protection against subsequent challenge with WT sporozoites, we investigated the immunization potential of p36p Ϫ sporozoites. Mice were i.v. immunized with p36p Ϫ sporozoites by using different immunization protocols and subsequently challenged with WT parasites. Protection was determined by using two different detection assays. (i) In three independent experiments, groups of four BALB͞c mice were infected with either 10 5 p36p Ϫ sporozoites or 10 5 RAS. After 10 days, mice were challenged with 5 ϫ 10 4 WT sporozoites and assessed for liver stage development by using real-time PCR assays to quantify A-type ribosomal RNA transcripts produced by developing trophozoites (36) . Mice immunized with RAS and p36p Ϫ sporozoites showed a very strong and comparable reduction (Ͼ99%) in liver stage development of WT parasites compared to nonimmunized mice (Fig. 4 , which is published as supporting information on the PNAS web site). (ii) In several independent experiments groups of BALB͞c and C57BL6 mice were immunized with a single dose of 10 to 5 ϫ 10 4 p36p Ϫ sporozoites or multiple times (one to three immunizations) with 5 to 2 ϫ 10 4 p36p Ϫ sporozoites, respectively, and challenged with different doses of WT sporozoites on different days after immunization (Table 2) . Protection was determined by monitoring mice intermittently for blood stage parasitemia in bloodsmears or using FACS analysis from day 3 to 3 weeks after challenge.
A single immunization dose of p36p Ϫ sporozoites fully protected BALB͞c mice (53 of 55) and induced a protective immune response that lasted for at least 4 months (120 days), whereas three subsequent immunizations with p36p Ϫ sporozoites were required to completely protect C57BL6 mice (9 of 9), resulting in a protective immune response that lasted for at least one month (30 days), as shown by the absence of subsequent blood stage infection after challenge with WT sporozoites. Furthermore, in two nonprotected BALB͞c mice (Table 2 ; experiment 1) liver development was strongly inhibited (Ϸ10 3 ), as shown by a 3-day delay in patent parasitemia. Five protected BALB͞c animals ( Table 2 ; experiment 1) were rechallenged, 1 and 2 months after immunization, respectively, with WT sporozoites and did not develop blood stage infections up to 2 weeks after challenge. C57BL6 mice were partially protected when immunized only twice with either RAS (33%) or p36p Ϫ sporozoites (25%) ( Table 2 ). The protective immune response induced by p36p Ϫ sporozoites as well as RAS sporozoites seemed to be parasite stage-specific, because BALB͞c mice were not protected from a challenge with parasite-infected red blood cells and developed a normal blood stage infection comparable to the control group (Table 2) .
Discussion
The lack of significant progress with (recombinant) subunit vaccines that contain only (parts of) single proteins of sporozoites has led to renewed interest in vaccines based on live, attenuated whole sporozoites (12) . Recently, it has been shown that GAS, like RAS, produced by engineered inactivation of sporozoite-specific genes can induce protective immunity in the P. berghei rodent model of malaria (16, 17) . Our studies demonstrate another example of GAS that is produced through the inactivation of the sporozoite-specific protein P36p and induces protective immunity. P36p is a member of the P48͞45 family of surface proteins (21) that include a number of promising vaccine candidate antigens, such as P48͞45 and P230 that are expressed on the surface of gametes (20, 22) . P36p has no function in sporozoite motility and invasion of both salivary glands and hepatocytes, and instead plays an essential role during development of the liver trophozoite. P36p Ϫ parasites apparently fail to maintain a PV, arresting early during intrahepatocytic development; importantly, immunization with p36p Ϫ sporozoites induces a fully protective immune response against subsequent challenge with WT sporozoites. Interestingly, as has been shown for RAS, only a single immunizing dose of p36p Ϫ sporozoites is required to elicit a long-lasting protective immune response in BALB͞c mice (40) and induces a protective immune response that is parasite stage specific (16, 17) . As in the immunization studies performed with uis3 Ϫ and uis4 Ϫ GAS (16, 17) and RAS (40) , three immunizing doses of p36p Ϫ sporozoites are required to completely protect C57BL6 mice for minimally 1 month. Furthermore, our results demonstrate that the choice of the host strain in studying the mechanisms of protective immunity induced by attenuated sporozoites is critical, as has been shown by earlier studies (40) . Intriguingly, p36p Ϫ sporozoites, like uis4 Ϫ GAS, albeit at a lower frequency, initiated a delayed blood stage infection in some mice, but only when p36p Ϫ sporozoites are inoculated i.v. The reasons for this are unclear and await further investigation. There is a close paralogue of p36p, p36 that is also expressed in sporozoites (E. Lasonder, personal communication) and located directly adjacent to p36p in the parasite genome. Improved levels of protection may be achieved by creating a double p36p Ϫ ͞p36p Ϫ parasite. It is now possible to consider a comparative study of the intrahepatocytic development and the mechanism(s) of immunity invoked by different GAS and RAS. Like GAS, RAS sporozoites invade liver cells and transform into the rounded trophozoite stage, but do not enter the process of schizogony. However, trophozoite development of RAS arrests at a later stage and produces a visible PV compared to p36p Ϫ sporozoites. Moreover, RAS-infected hepa- tocytes persist in culture longer than their GAS-infected counterparts, which, in the case of p36p Ϫ parasites, results from their failure to prevent the host cell from entering apoptosis. Although RAS populations provoke apoptosis to a greater degree than WT sporozoites, they do so to a significantly lower degree than p36p Ϫ sporozoites. We also determined in vivo the persistence of RASand p36p Ϫ -infected hepatocytes in whole liver extracts of BALB͞c mice by using real-time PCR for liver schizont detection (36) . Our results confirm the significantly more rapid clearance of p36p Ϫ parasitized hepatocytes within 6 h after infection compared to RAS-infected hepatocytes as has been observed in vitro (data not shown). However, similar low numbers of RAS-and p36p Ϫ -infected hepatocytes are observed 1 week after infection.
Immune responses against RAS are complex and involve both cell-mediated and humoral immunity (13) (14) (15) . However, the differing biological characteristics of RAS and GAS described here suggest that the immune responses elicited by RAS and GAS could be different. For example, cell death by apoptosis was originally described to occur in the absence of inflammation. Interestingly, in the context of infection, apoptosis is being redefined based on a number of studies demonstrating that apoptotic death of host cells after pathogen infection can trigger powerful innate and adaptive immune responses. In fact, apoptosis-induced inflammation is actively being investigated as a way of enhancing vaccine function improving accessibility of the effector cells of the immune system to the site of infection (41, 42) . Moreover, presentation of parasite antigens in the context of host cell apoptosis has recently been shown as an alternative mechanism involved in the induction of protective immunity by RAS (43) . As apoptosis of p36p Ϫ -infected hepatocytes was also detected in vivo, it might well be that host-cell apoptosis is associated with the ability of p36p Ϫ sporozoites and other GAS to induce protective immune responses and needs further investigation.
The mechanisms and (parasite) molecules involved in preventing host cell apoptosis by intracellular parasites including apicomplexans are being investigated (44, 45) . Recently, it has been shown that Plasmodium parasites exploit the host molecule hepatocyte growth factor (HGF), secreted exclusively by hepatocytes damaged by parasite transit (32) , to activate anti-apoptotic signaling pathways in the host cell through HGF͞MET signaling (34) . The ability of the p36p Ϫ sporozoites to invoke this pathway is currently unknown; however, such interactions might now be explored in greater detail. In particular, these studies will benefit from the use of a battery of GFP-expressing parasites available in our laboratory, including (radiation-attenuated) WT parasites expressing GFP constitutively (PbGFPcon) (23) and the p36p Ϫ :gfp parasites reported here. These GFP-expressing lines will, for example, provide a means to purify by flow sorting cultured, infected hepatocytes containing aborted parasites allowing a detailed analysis of the transcriptome and proteome of both parasite and host cells and as a consequence shed more light on the parasite strategies used to influence host cell apoptosis.
Furthermore, our studies show that p36p Ϫ sporozoites are able to invade hepatocytes but seem to be unable to produce a mature PVM, which might be a critical step in the intracellular survival of the parasite. It might well be that the presence of a PVM is essential in escaping from host defense mechanisms (avoiding internal cellular surveillance by the hepatocyte). Indeed, if the parasite enters the host cell either without a PVM or with an incomplete PVM, infection may be readily detected by the host cell, and this may in turn trigger xenophagy, leading ultimately to an inflammatory apoptotic response (46) . Therefore, the attenuated parasite may survive only as long as either the killing response of the host cell allows or the parasite can avoid or neutralize the host cell defense mechanisms.
P36p may be essential for intracellular survival͞development through being involved in an essential preceding step affecting gene-expression through signaling; therefore, the absence of P36p results in the lack of the necessary parasite mediators that control parasite survival, formation and͞or maintenance of an effective PV, and direct involvement in the regulation of the host cells apoptotic machinery. Interestingly, P36p is anticipated to be a GPI-anchored membrane protein and, therefore, may play a role in the interactions between the developing trophozoite and its host cell.
